Your browser doesn't support javascript.
loading
The janus face of serotonin: Regenerative promoter and chronic liver disease aggravator.
Mao, Benliang; Liu, Shoupei; Zhu, Shanfei; Wu, Fan; Yuan, Wei; Yan, Yong; Wang, Bailin.
Affiliation
  • Mao B; Department of General Surgery, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
  • Liu S; College of Clinical Medicine, Guizhou Medical University, Guiyang, China.
  • Zhu S; Laboratory of Stem Cells and Translational Medicine, Institutes for Life Sciences, School of Medicine, South China University of Technology, Guangzhou, China.
  • Wu F; Department of General Surgery, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
  • Yuan W; Department of General Surgery, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
  • Yan Y; Department of General Surgery, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
  • Wang B; Department of General Surgery, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
Heliyon ; 10(9): e30703, 2024 May 15.
Article in En | MEDLINE | ID: mdl-38756588
ABSTRACT
The progression of liver diseases, from viral hepatitis and fatty liver disease to cirrhosis and hepatocellular carcinoma (HCC), is the most representative series of pathological events in liver diseases. While serotonin (5-HT) primarily regulates brain functions such as psychology, mood, and appetite in the central nervous system (CNS), peripheral 5-HT plays a crucial role in regulating tumor development, glucose and lipid metabolism, immune function and inflammatory response related to liver diseases. These peripheral physiological processes involving 5-HT are the key mechanisms driving the development of these liver diseases. This study presents an overview of the existing literature, focusing on the role of 5-HT in HCC, cirrhosis, fatty liver disease, viral hepatitis, and liver injury. In summary, while 5-HT promotes liver regeneration, it can also contribute to the progression of chronic liver disease. These findings indicate the potential for the development and use of 5-HT-related drugs for the treatment of liver diseases, including HCC and cirrhosis.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2024 Document type: Article Affiliation country: China Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Heliyon Year: 2024 Document type: Article Affiliation country: China Country of publication: Reino Unido